INS and cancer: The subset of oncogenic signaling pathways includes: pathways in cancer, p53 signaling, transcriptional misregulation in cancer, insulin signaling, TGF-beta signaling, PI3K-Akt signaling, MAPK signaling, cell cycle, and HIF-1 signaling pathways (Table 6).